Trade and Investment

Countries must rethink tariffs on bio-manufacturing

A worker of Bidafarma shows Pfizer-BioNTech COVID-19 vaccines at the Spanish pharmaceutical distributor 'Bidafarma' Granada warehouse, amid the coronavirus disease (COVID-19) outbreak, in Santa Fe, near Granada, southern Spain February 1, 2021.

Image: REUTERS/Jon Nazca

Thaddeus Burns
Head of Life Science Government & Public Affairs, Merck
Jennifer Brant
CEO, Innovation Insights
Share:
Our Impact
The Big Picture
Explore and monitor how Trade and Investment is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Trade and Investment

Have you read?
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

International trade: what you need to know this month

Edgard Carneiro Vieira

September 18, 2023

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum